読み込み中
HKSEHealthcareMedical - Devices
最新データ
HK$20.10
−HK$0.24 · -1.18%
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
最新データ
HK$20.10
−HK$0.24 · -1.18%
日中の時刻はHKTです。市場データは遅延する場合があります。
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
日中レンジ
現在 HK$20.10
52週レンジ
現在 HK$20.10
日中の時刻はHKTです。市場データは遅延する場合があります。
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
日中レンジ
現在 HK$20.10
52週レンジ
現在 HK$20.10
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（CNY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 10.57億 CNY | 7.82億 CNY | 5.28億 CNY | 3.34億 CNY | 1.78億 CNY |
| 売上原価 | 2.95億 CNY | 2.23億 CNY | 1.43億 CNY | 8142.1万 CNY | 4603.1万 CNY |
| 粗利益 | 7.63億 CNY | 5.6億 CNY | 3.85億 CNY | 2.53億 CNY | 1.32億 CNY |
| 研究開発 | 2.47億 CNY | 2.33億 CNY | 2.61億 CNY | 2.33億 CNY | 1.68億 CNY |
| 販売・一般管理 | 3.16億 CNY | 2.66億 CNY | 2.78億 CNY | 2.49億 CNY | 1.96億 CNY |
| 営業費用 | 5.63億 CNY | 4.99億 CNY | 5.42億 CNY | 4.75億 CNY | 3.5億 CNY |
| 受取利息 | 5463.74万 CNY | 6734.5万 CNY | 7904万 CNY | 9556.5万 CNY | 1309.4万 CNY |
| 支払利息 | 99.65万 CNY | 217.5万 CNY | 125.1万 CNY | 72.2万 CNY | 30.7万 CNY |
| 減価償却費と償却費 | 3726.52万 CNY | 3784.7万 CNY | 3588万 CNY | 2626.8万 CNY | 1338.2万 CNY |
| 営業利益 | 1.97億 CNY | 6091.5万 CNY | −1.57億 CNY | −2.08億 CNY | −2.12億 CNY |
| 純利益 | 2.44億 CNY | 1億 CNY | −7873.4万 CNY | −1.14億 CNY | −2億 CNY |
会社概要が更新されました 2026年10月16日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core MSCI Emerging Markets ETFIEMG445.19万0.00%1545.08億 USD0.09%$77.49-0.77%
Avantis Emerging Markets Equity ETFAVEM24.4万—274.87億 USD0.33%$89.645-0.84%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX17.49万0.03%6.66億 USD0.65%$69.975-0.49%
iShares MSCI China Small-Cap ETFECNS17.11万0.29%5918.28万 USD0.59%$26.790.00%
iShares MSCI Emerging Markets Small-Cap ETFEEMS11.79万0.03%3.82億 USD0.72%$73.65-0.36%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM8.15万0.00%92.26億 USD0.39%$38.1661-0.76%
Dimensional - Emerging Core Equity Market ETFDFAE5.75万0.00%95.59億 USD0.29%$37.57-0.79%
Avantis Emerging Markets Small Cap Equity ETFAVEE4.53万0.03%1.35億 USD0.42%$67.850.00%iShares Core MSCI Emerging Markets ETFIEMGAvantis Emerging Markets Equity ETFAVEMState Street SPDR S&P Emerging Markets Small Cap ETFEWXiShares MSCI China Small-Cap ETFECNSiShares MSCI Emerging Markets Small-Cap ETFEEMSDimensional - Emerging Markets Core Equity 2 ETFDFEMDimensional - Emerging Core Equity Market ETFDFAEAvantis Emerging Markets Small Cap Equity ETFAVEEAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
